Gold$2,045.30+0.52%
Silver$23.84-0.18%
Copper$3.85+1.23%
Platinum$912.40-0.33%
Iron Ore$118.50+2.14%
Nickel$16,892-0.89%
Albemarle Corporation logo

Albemarle Corporation

ALBLarge CapLithium

Price History

Loading chart...

About Albemarle Corporation

Overview

Albemarle Corporation is the world's largest lithium producer and a global specialty chemicals company. The company produces lithium, bromine, and catalysts for diverse applications with particular focus on lithium for EV batteries. Albemarle operates an integrated global network of lithium production facilities spanning hard rock, brine, and conversion assets across multiple continents.

Operations

Albemarle operates lithium production from multiple sources: the Greenbushes hard rock mine in Western Australia (49% joint venture with Tianqi Lithium), Silver Peak brine operation in Nevada, Salar de Atacama brine operations in Chile, and conversion facilities in the US, Chile, and China. The company produces lithium hydroxide, lithium carbonate, and specialty lithium compounds, with total production capacity exceeding 200,000 tonnes LCE.

Strategy

The company's strategy focuses on aggressively expanding lithium production capacity to meet surging EV demand with targets of 500,000+ tonnes LCE by 2027, investing in conversion capacity globally, leveraging diversified raw material sources (hard rock, brines, clay), maintaining technology leadership in extraction and processing, securing strategic customer relationships, and delivering superior returns through the lithium super-cycle.

Key Projects

Major projects include Kemerton lithium hydroxide plants 1 and 2 in Australia (expansions underway), Meishan lithium hydroxide plant in China (under construction), Qinzhou conversion facility in China, Silver Peak expansion in Nevada, potential development of Kings Mountain lithium mine in North Carolina (restarting historic operation), and lithium extraction from claystone deposits. Albemarle is investing billions in capacity expansion globally.

Primary Commodities

LithiumBromine

Financial Metrics

Loading financial data...

Press Releases

PRESS RELEASE

Lithium ETF LIT Returned 125% to Investors Who Bought at Last Year’s Low

A year ago, lithium was the trade nobody wanted. The Global X Lithium & Battery Tech ETF (NYSEARCA:LIT) had been bleeding for the better part of three years, EV demand headlines were a graveyard, and the consensus take was that oversupply from Chinese converters would keep lithium carbonate prices pinned to the floor through the ... Lithium ETF LIT Returned 125% to Investors Who Bought at Last Year’s Low

Yahoo Finance10 hours ago
PRESS RELEASE

Albemarle CFO Takes On Interim Accounting Role As Oversight Scrutinized

Albemarle (NYSE:ALB) has appointed Chief Financial Officer Neal R. Sheorey as interim Principal Accounting Officer. The change follows the retirement of Chief Accounting Officer Donald J. LaBauve Jr. The move concentrates key finance and accounting responsibilities under the current CFO. For a stock that has risen 8.0% year to date and 164.4% over the past year, any adjustment in senior finance leadership is worth noting. Albemarle's current share price of $155.44 comes after the stock...

Yahoo Finance4 hours ago
PRESS RELEASE

Why Is Albemarle (ALB) Down 16.5% Since Last Earnings Report?

Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo Finance10 hours ago
PRESS RELEASE

BASFY Launches InVigor Gold L322 to Expand US Canola Production

BASFY debuts InVigor Gold L322 canola hybrid, aiming to push U.S. acreage into hotter, drier regions, with Montana launch eyed for 2027.

Yahoo Finance13 hours ago
PRESS RELEASE

IP Expands Capabilities in West Coast Region With NORPAC Acquisition

International Paper expands its West Coast footprint with the $360M NORPAC acquisition, adding containerboard capacity and boosting packaging capabilities.

Yahoo Finance1 hour ago
PRESS RELEASE

NTR's Shares Rise 17% in 6 Months: What's Driving the Upside?

Nutrien gains on strong fertilizer demand, rising prices and cost cuts, with record potash volumes boosting earnings momentum.

Yahoo Finance2 hours ago
PRESS RELEASE

Albemarle (ALB) Stock Slides as Market Rises: Facts to Know Before You Trade

Albemarle (ALB) closed at $165.65 in the latest trading session, marking a -1.6% move from the prior day.

Yahoo Finance4 hours ago
PRESS RELEASE

Albemarle (ALB) Valuation Check As Upgraded Earnings Outlook Meets Cost Cuts And Insider Selling Concerns

Recent upgrades to Albemarle (ALB) earnings forecasts and renewed optimism around its cost cuts and capital spending have refocused attention on the stock, even as valuation concerns and insider selling remain in the background. See our latest analysis for Albemarle. The share price has pulled back recently, with a 1-day share price return of 2.0% and a 30-day share price return of 11.72% down. At the same time, the year-to-date share price return of 16.96% and a 1-year total shareholder...

Yahoo Finance10 hours ago
PRESS RELEASE

Valmont Industries' Stock Scale Fresh 52-Week High: Here's Why

VMI hits a fresh 52-week high after Q1 profit jump 27.5%, and it lifts 2026 EPS guidance as Infrastructure expansion stays on track.

Yahoo Finance10 hours ago
PRESS RELEASE

ATI Prices $450 Million Senior Notes Offering Due in 2033

ATI prices $450M of 5.875% senior notes due 2033, earmarking $350M to redeem its 2027 notes.

Yahoo Finance10 hours ago

Quick Facts

Ticker Symbol
ALB
Market Cap
Large Cap
Category
Lithium
Commodities
Lithium, Bromine
Headquarters
Charlotte, North Carolina, USA
Founded
1994
Employees
~6,000

Operating Countries

AustraliaChileUSAChina

Producing Assets

  • Greenbushes (Australia)
  • Silver Peak (USA)
  • Salar de Atacama (Chile)
  • Conversion facilities (Global)

Development Assets

  • Kemerton (Australia)
  • Kings Mountain (USA)
  • Multiple expansions globally

This information is for educational purposes only and does not constitute investment advice. Always conduct your own research before making investment decisions.

◆ ◆ ◆